abstract |
The invention is directed to pyrro[1,2-b]pyridazinone compounds of Formula I and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus: n nwherein R 4 is selected fromn n nRing A is 5 or 6- membered aryl or heterocyclyl, and the remaining substituents are defined herein. |